BioMérieux: in the green on broker's comments

(CercleFinance.com) - Bucking the trend in Paris, bioMérieux gained 1% on favorable comments from UBS, which reaffirmed its 'buy' recommendation and raised its target price for the in vitro diagnostics specialist from 129 to 138 euros.


Prior to the quarterly publication on March 7, the multiple does not reflect the probability of one of the cleanest, most balanced and fastest growth forecasts in the sector", the broker judges in the summary of its note.

Copyright (c) 2025 CercleFinance.com. All rights reserved.